EverSource Wealth Advisors’s Denali Therapeutics DNLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61K | Sell |
115
-316
| -73% | -$4.42K | ﹤0.01% | 3563 |
|
|
2025
Q1 | $5.86K | Buy |
431
+135
| +46% | +$1.84K | ﹤0.01% | 2416 |
|
|
2024
Q4 | $6.03K | Sell |
296
-21
| -7% | -$428 | ﹤0.01% | 2260 |
|
|
2024
Q3 | $9.23K | Hold |
317
| – | – | ﹤0.01% | 1913 |
|
|
2024
Q2 | $7.73K | Buy |
317
+25
| +9% | +$609 | ﹤0.01% | 2008 |
|
|
2024
Q1 | $4.51K | Buy |
292
+34
| +13% | +$525 | ﹤0.01% | 2095 |
|
|
2023
Q4 | $5.54K | Buy |
258
+42
| +19% | +$901 | ﹤0.01% | 1817 |
|
|
2023
Q3 | $4.46K | Buy |
216
+172
| +391% | +$3.55K | ﹤0.01% | 1745 |
|
|
2023
Q2 | $1.3K | Buy |
+44
| New | +$1.3K | ﹤0.01% | 2140 |
|
|
2022
Q2 | – | Sell |
-51
| Closed | -$2K | – | 1756 |
|
|
2022
Q1 | $2K | Hold |
51
| – | – | ﹤0.01% | 1511 |
|
|
2021
Q4 | $2K | Buy |
+51
| New | +$2K | ﹤0.01% | 1530 |
|